Purpose: To assess the effectiveness and safety of Chinese herbal medicine (CHM) for the treatment of acute pelvic inflammatory disease (PID).
1 Primary Care and Population Sciences, University of Southampton 2 Mathematical Sciences, University of Southampton Purpose: Randomised controlled trials (RCTs) evaluate effectiveness of Chinese herbal medicines (CHMs) in the West, yet little is known regarding CHM adherence amongst these populations. We aimed to evaluate feasibility of collecting adherence data within a UK study and identify strategies for improving adherence.
Methods: We conducted a feasibility study exploring CHM for polycystic ovary syndrome, randomising 40 women to either standardised CHM or individualised CHM. This was prescribed for 24 weeks at 8 g granules/dose, two dosages daily, taken as a tea. Practitioners and participants were blinded. We evaluated adherence using Morisky Medication Adherence Scale (MMAS) at Week 4 and end of study (EoS); weighing prescriptions at Week 12 and EoS, and process data.
Results: Mean completion rates were high for MMAS (87.5%). Weighing data was complete for 15 (37.5%) participants, incomplete for 15 (37.5%) and absent for 10 (25%). MMAS data suggests low adherence to both CHM interventions at Week 4 and EoS. Small improvements within-group were observed for both standardised CHM (MD 0.9, 95% CI -0.3 to 2.0) and individualised CHM (MD 1.0, 95% CI 0. 3 to 1.8) but which were statistically significant only for individualised. When explored as a categorical variable, improvement from low to medium or high adherence was found in 4 participants from each of the two groups. We used weighing data to estimate a mean of 65% (SD21.2) of CHMs were administered, suggesting a dose of 10-11 g/day is more feasible. Process data suggests adherence could be improved by changing administration to tablet/capsules and reducing to once daily dosing.
Conclusion: To our knowledge, this is the first rigorous evaluation of CHM treatment adherence carried out in the UK. This study has uncovered important findings regarding CHM adherence in a Western population and will help inform the design of the CHM intervention for a main study.
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